Aarti Pharmalabs has announced a board meeting to discuss the financial results for the quarter and half-year. An earnings conference call will follow, featuring the Chairman, Vice Chairperson & MD, and CFO, focusing on reviewing the Q4-FY25 and FY25 audited results with investors and analysts.